clinical trial · NCT01168791
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma
Alaunos Therapeutics·phase3·terminated·n = 447
Soft Tissue SarcomaPalifosfamide-TrisdoxorubicinPlacebo
brief summary
This is an international, randomized, double-blind, placebo-controlled trial to evaluate the clinical efficacy of palifosfamide-tris administered with doxorubicin in combination, compared with doxorubicin administered with placebo in front-line patients diagnosed with metastatic soft tissue sarcoma (STS).
started
Aug 16, 2010
primary completion
Mar 13, 2013
completion
Mar 13, 2013
last updated
Oct 1, 2026
official title
A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol